Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately.
●(See "Society guideline links: Primary prevention of cardiovascular disease".)
●(See "Society guideline links: Obesity in adults".)
●(See "Society guideline links: Menopause".)
●(See "Society guideline links: Non-ST-elevation acute coronary syndromes (non-ST-elevation myocardial infarction)".)
●(See "Society guideline links: ST-elevation myocardial infarction (STEMI)".)
●(See "Society guideline links: Chronic coronary syndrome".)
●(See "Society guideline links: Occlusive carotid, aortic, renal, mesenteric, and peripheral atherosclerotic disease".)
International
●World Health Organization (WHO): Prevention of cardiovascular disease − Guidelines for assessment and management of cardiovascular risk (2007)
Canada
●Canadian Association of Cardiac Rehabilitation (CACR) and Canadian Cardiovascular Society (CCS): Society position statement for systemizing inpatient referral to cardiac rehabilitation 2010 (published 2011)
●CCS: Society position statement on smoking cessation and the cardiovascular specialist (2011)
United States
●American College of Cardiology (ACC): Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes (2020)
●ACC: Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes and atherosclerotic cardiovascular disease (2018)
●American Heart Association (AHA)/ACC/American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)/American Association Academy of Physician Assistants (AAPA)/Association of Black Cardiologists (ABC)/American College of Preventive Medicine (ACPM)/American Diabetes Association (ADA)/American Geriatrics Society (AGS)/American Pharmacists Association (APhA)/American Society for Preventive Cardiology (ASPC)/ National Lipid Association (NLA)/Preventive Cardiovascular Nurses Association (PCNA): Guideline on the management of blood cholesterol (2018)
●ACC: 2016 expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk, focused update (published 2017)
●AHA: A scientific statement on meditation and cardiovascular risk reduction (2017)
●ACC/AHA: 2015 secondary prevention lipid performance measures, focused update (published 2016)
●Choosing Wisely: Do not routinely order expanded lipid panels (particle sizing, nuclear magnetic resonance) as screening tests for cardiovascular disease (2016)
●AHA: A scientific statement for secondary prevention after coronary artery bypass graft surgery (2015)
●AHA/ACC/The Obesity Society (TOS): 2013 guideline for the management of overweight and obesity in adults (published 2014)
●ACC/AHA: Guideline on the assessment of cardiovascular risk (2013)
●AHA: Scientific statement for secondary prevention of atherosclerotic cardiovascular disease in older adults (2013)
●American Association of Clinical Endocrinologists (AACE)/American College of Endocrinology (ACE) and TOS: Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults (2013)
●American Society for Nutrition (ASN): Scientific statement on consumption of cereal fiber, mixtures of whole grains and bran, and whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease (2013)
Europe
●European Society of Cardiology (ESC): Guidelines on cardiovascular disease prevention in clinical practice (2021)
●European Association of Preventive Cardiology (EAPC): A position paper on exercise training for patients with type 2 diabetes and cardiovascular disease (2019)
●ESC: Guidelines on management of dyslipidaemias ─ Lipid modification to reduce cardiovascular risk (2019)
●ESC and the European Association for the Study of Diabetes (EASD): Guidelines on diabetes, pre-diabetes, and cardiovascular diseases (2019)
●ESC: 2015 guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (published 2016)
United Kingdom
●National Institute for Health and Care Excellence (NICE): Guideline on acute coronary syndromes (2020)
●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on cardiac rehabilitation (2017)
●SIGN: A national clinical guideline on risk estimation and the prevention of cardiovascular disease (2017)
●NICE: Clinical guideline on cardiovascular disease − Risk assessment and reduction, including lipid modification (2014, updated 2016)
●NICE: Quality standard on cardiovascular risk assessment and lipid modification (2015)
Australia-New Zealand
●National Heart Foundation of Australia (NHFA) and Cardiac Society of Australia and New Zealand (CSANZ): Australian clinical guidelines for the management of acute coronary syndromes (2016)
●NHFA and CSANZ: Reducing risk in heart disease − An expert guide to clinical practice for secondary prevention of coronary heart disease (2012)
●National Vascular Disease Prevention Alliance (NVDPA): Guidelines for the management of absolute cardiovascular disease risk (2012)
Japan
●[In Japanese] Japanese Circulation Society (JCS)/Japanese Association of Cardiac Rehabilitation (JACR): Guideline on rehabilitation in patients with cardiovascular disease (2021)
